NanHua Bio-medicine 南华生物

Healthcare Services 医疗服务

¥13.73+¥0.97 · +7.60%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY

Open 开盘

¥11.62

High 最高

¥14.04

Low 最低

¥11.62

Prev Close 昨收

¥12.76

Volume 成交量

1.15亿股

Turnover 成交额

¥15亿

Mkt Cap 总市值

¥45亿

P/E 市盈率

118.3×

Recent Activity 近期动态All Filings 全部公告 →

5 significant filings since 31 May 2026: 2 on regulatory inquiry, 1 on earnings pre-announcement and 1 on delisting warning lifted, and 1 other kind. The latest, on 10 Jul 2026: 2026-037 南华生物2026年半年度业绩预告的公告. On 10 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 220.54% to 277.94% from the same period a year earlier.
自 31 May 2026 起有 5 份重大公告：regulatory inquiry 2 份、earnings pre-announcement 1 份、delisting warning lifted 1 份，另有 1 类。最新一份（10 Jul 2026）：2026-037 南华生物2026年半年度业绩预告的公告。10 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 220.54% 至 277.94%。

Price History 价格走势

5 sessions 个交易日, 18 Sep to 24 Sep 2026 · Live one-minute prices · High 最高 ¥14.04 · Low 最低 ¥9.76 · +7.60% on the previous close of ¥12.76

1D 5D 1M 3M 1Y 5Y Max

10.0011.0012.0013.0014.00

Volume 成交量

12.4万

18 Sep21 Sep22 Sep23 Sep24 Sep

Overview 概览 Deep Report 深度报告 Financials 财务 Valuation 估值 Ownership 股东 Analysts 券商 Estimates 预测 News 动态 Events 事件 Peers 同业

Estimates 盈利预测

No broker reports from the last twelve months are held for this company. Brokers covered 1,059 of the 2,940 SZSE listings (36%) over the same period. 近十二个月无本公司研报；同期券商覆盖了 2,940 只 SZSE 证券中的 1,059 只（36%）。